Funding Opportunity RFA-OD-21-007 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites researchers to submit applications for support of new exploratory and developmental research projects that address critical needs for Down syndrome projects, as articulated in the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) project objectives. For example, such projects could assess the feasibility of a novel area of investigation or a new experimental system that has the potential to enhance health-related research. Another example could include the unique and innovative use of an existing methodology to explore a new scientific area. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research.

Funding Opportunity RFA-MH-22-100 from the NIH Guide for Grants and Contracts. This FOA seeks research applications for effectiveness and implementation science on the post-acute (long-term or chronic) management of mental health conditions. This funding opportunity aims to advance the development of novel and innovative implementation research to improve the availability and accessibility of post-acute services in low- and middle-income countries (LMICs) and low resource settings. As such, all successful applications are expected to provide approaches to obtain new information concerning the different health system arrangements and using this information to identify modifiable a restrictions in the supply of these services and potential policy interventions to alter the status quo.

Competitive Salary: EMBL: An exciting opportunity has been created for a talented scientist to work on the development of novel computational and informatics methods to improve Hinxton, Cambridgeshire, England

Funding Opportunity RFA-AG-22-029 from the NIH Guide for Grants and Contracts. The purpose of the Caenorhabditis Interventions Testing Program (CITP) is to test, under standardized conditions at a consortium of three sites, potential intervention strategies that may moderate/alleviate health declines associated with aging across genetically diverse species and strains of Caenorhabditis.

Notice NOT-CA-21-119 from the NIH Guide for Grants and Contracts

Notice NOT-DE-21-014 from the NIH Guide for Grants and Contracts

Notice NOT-HS-21-021 from the NIH Guide for Grants and Contracts

Notice NOT-OD-21-177 from the NIH Guide for Grants and Contracts

Notice NOT-AR-22-007 from the NIH Guide for Grants and Contracts

Notice NOT-HD-21-045 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-CA-21-059 from the NIH Guide for Grants and Contracts. The purpose of the NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) is to encourage and retain outstanding graduate students recognized by their institutions for their high potential and strong interest in pursuing careers as independent cancer researchers. The award will facilitate the transition of talented graduate students into successful cancer research postdoctoral appointments and provide opportunities for career development activities relevant to their long-term career goals of becoming independent cancer researchers.

Funding Opportunity PAR-21-329 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support collaborative research projects designed to address adverse sequelae of cancer therapies that persist and become chronic comorbidities or develop as delayed posttreatment effects. This FOA supports basic, translational, and clinical research projects that seek to identify the mechanisms of therapy-induced adverse sequelae, clinically characterize the adverse sequelae, or translate the mechanistic understanding into therapeutic approaches to prevent or minimize the development of long-term sequelae. Research projects should focus on mechanistic studies with translational endpoints and longitudinal clinical phenotyping to identify and validate clinical endpoints (biomarkers, imaging, patient-reported outcomes, or combined elements) for future use in clinical trials that will evaluate the efficacy of interventions designed to prevent or reduce specific adverse sequelae.

Funding Opportunity PAR-21-338 from the NIH Guide for Grants and Contracts. The National Center for Advancing Translational Sciences (NCATS) will award Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Institutional Research Training Grants for the Clinical and Translational Science Awards (CTSA) Program (T32) to eligible institutions to enhance postdoctoral research training of individuals with health professional degrees and help ensure a heterogenous pool of clinical and translational scientists trainees are equipped with the knowledge, skills and abilities to advance diagnostics, therapeutics, clinical interventions, and behavioral modifications that improve health.

Funding Opportunity PAR-21-337 from the NIH Guide for Grants and Contracts. The National Center for Advancing Translational Sciences (NCATS) will award Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Institutional Research Training Grants for the Clinical and Translational Science Awards (CTSA) Program (T32) to eligible institutions to enhance predoctoral research training of individuals seeking health professional degrees and help ensure a heterogenous pool of clinical and translational scientist trainees who are equipped with the knowledge, skills and abilities to advance diagnostics, therapeutics, clinical interventions, and behavioral modifications aimed at improving health.

Notice NOT-DK-21-029 from the NIH Guide for Grants and Contracts

Notice NOT-CA-21-120 from the NIH Guide for Grants and Contracts

Notice NOT-DK-21-028 from the NIH Guide for Grants and Contracts

Notice NOT-DC-21-005 from the NIH Guide for Grants and Contracts

Notice NOT-MH-21-345 from the NIH Guide for Grants and Contracts

Notice NOT-DA-21-083 from the NIH Guide for Grants and Contracts